Encompass Health beats, raises 2026 EPS and revenue guidance

 

Encompass Health beats Q3 2026 estimates with adjusted EPS $1.52 on $1.61B revenue, raises 2026 EPS and revenue guidance

• Q3 2026 revenue grew 8.9% to $1.6B, exceeding analyst revenue estimates
• Adjusted EBITDA grew 15.5% in Q3 2026 for the quarter
• Company now guides 2026 EPS to $6.23-$6.37 and revenue to $6.45-$6.5 billion

https://finviz.com/stock?t=EHC&p=d